Details for New Drug Application (NDA): 017506
✉ Email this page to a colleague
The generic ingredient in ISOPAQUE 280 is calcium; meglumine; metrizoic acid. There are two hundred and eighty-two drug master file entries for this compound. Additional details are available on the calcium; meglumine; metrizoic acid profile page.
Summary for 017506
Tradename: | ISOPAQUE 280 |
Applicant: | Ge Healthcare |
Ingredient: | calcium; meglumine; metrizoic acid |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.35MG/ML;140.1MG/ML;461.8MG/ML | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No |
Expired US Patents for NDA 017506
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | ISOPAQUE 280 | calcium; meglumine; metrizoic acid | INJECTABLE;INJECTION | 017506-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription